SERB and Stark International’s $800 Million Acquisition of BTG Specialty Pharmaceuticals

Shearman & Sterling represented Boston Scientific in the transaction. Eight Advisory represented Serb. Mayer Brown represented Serb and Charterhouse.

Boston Scientific executed the pending sale of BTG Specialty Pharmaceuticals to SERB SAS and Stark International Lux S.A.R.L., portfolio companies of private equity firm Charterhouse Capital Partners, for a cash purchase price of $800 million.

BTG Specialty Pharmaceuticals develops, manufactures and commercializes life-saving antidotes used in hospitals and emergency care settings.

The transaction is expected to close in the first half of 2021, subject to receipt of regulatory approvals and clearances and the satisfaction of other customary closing conditions.

The Shearman & Sterling team included Clare O’brien (Picture), Derrick Lott, John J. Cannon, Jordan Altman, Laurence Bambino, Jay M. Singer, David A. Higbee, John M. Beahn, Sam Whitaker, Jonathan Cheng, Enrique Dancausa, Wendy Suh, Melisa Brower, Max Bradley, Marie-Alexis Valente, Sophie Zander, Adam Sternberg, Ryan Leske, Nick Withers, Frances Burchall, Joon Lee, Lavelle Simmons, and Noni Nelson.

The Eight Advisory team included  Dean Lake and Caley Mogg.

The Mayer Brown team included Laurent Borey, Olivier Parawan, Sarah Rahmoun, Alexandre Chagneau, Remmelt Reigersman and Matthew Mortimer.

Involved fees earner: Dean Lake – Eight Advisory; Caley Mogg – Eight Advisory; Laurent Borey – Mayer Brown; Alexandre Chagneau – Mayer Brown; Matthew Mortimer – Mayer Brown; Olivier Parawan – Mayer Brown; Sarah Rahmoun – Mayer Brown; Remmelt Reigersman – Mayer Brown; Jordan Altman – Shearman & Sterling; Laurence Bambino – Shearman & Sterling; John Beahn – Shearman & Sterling; Max Bradley – Shearman & Sterling; Melisa Brower – Shearman & Sterling; Frances Burchall – Shearman & Sterling; John Cannon III – Shearman & Sterling; Jonathan Cheng – Shearman & Sterling; Enrique Dancausa – Shearman & Sterling; David Higbee – Shearman & Sterling; Ryan Leske – Shearman & Sterling; Derrick Lott – Shearman & Sterling; Clare O’Brien – Shearman & Sterling; Jay Singer – Shearman & Sterling; Adam Sternberg – Shearman & Sterling; Wendy Suh – Shearman & Sterling; Marie-Alexis Valente – Shearman & Sterling; Sam Whitaker – Shearman & Sterling; Nick Withers – Shearman & Sterling; Sophie Zander – Shearman & Sterling;

Law Firms: Eight Advisory; Mayer Brown; Shearman & Sterling;

Clients: Boston Scientific Corporation; Charterhouse Capital Partners; SERB S.A.S.;

Print Friendly, PDF & Email

Author: Ambrogio Visconti